Effectiveness of the Schmetterling-NBI Program in Reducing Selective Eating and Improving Autonomic Regulation in Children with Autism Spectrum Disorder: A Randomized Controlled Trial
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
This randomized controlled trial evaluated the effectiveness of the Schmetterling-NBI Program™ in reducing selective eating behaviors, improving autism-related symptoms, and enhancing autonomic nervous system (ANS) regulation in children diagnosed with Autism Spectrum Disorder (ASD). A total of 24 children with ASD and selective eating were randomly assigned to an experimental group (n = 12) receiving the Schmetterling-NBI Program™ or a control group (n = 12) receiving standard care. Outcomes were assessed using the Child Eating Behavior Questionnaire (CEBQ), the Childhood Autism Rating Scale, Second Edition (CARS-2), and heart rate variability (HRV) parameters, including standard deviation of normal-to-normal intervals (SDNN) and stress index. Children in the experimental group demonstrated significant reductions in selective eating behaviors (CEBQ: Z = 16.39, p < 0.001), as well as improvements in autism symptom severity (CARS-2: F = 23.26, p < 0.001), compared to the control group. HRV analyses revealed marked physiological improvements, with increased SDNN (Z = -74.07, p < 0.001) and reduced stress index (Z = 23.54, p < 0.001), indicating enhanced autonomic regulation. These findings suggest that the Schmetterling-NBI Program™ is an effective multidisciplinary intervention for improving selective eating behaviors, reducing autism-related symptoms, and promoting physiological well-being in children with ASD.